Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
2.440
+0.020 (0.83%)
At close: Oct 9, 2026, 4:00 PM EDT
2.480
+0.040 (1.64%)
After-hours: Oct 9, 2026, 7:36 PM EDT
Atossa Therapeutics Stock Forecast
ATOS's stock price has decreased by -85.35% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, Atossa Therapeutics stock has an average price target of $19. The average 1-year stock price forecast is 678.69% higher than the current stock price, while the lowest is $10 (+309.84%) and the highest is $25 (+924.59%).
Price Target: $19 (+678.69%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
According to 1 stock analyst, the rating for Atossa Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant | Ascendiant | Buy Maintains $24 → $25 | Buy | Maintains | $24 → $25 | +924.59% | Sep 30, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $20 → $10 | Buy | Maintains | $20 → $10 | +309.84% | Aug 11, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $12 | Buy | Initiates | $12 | +391.80% | Jul 7, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.56
from -4.04
EPS Next Year
-3.30
from -3.56
EPS and Forward PE are based on non-GAAP adjusted numbers.